Home » Stocks » Co-Diagnostics

Co-Diagnostics, Inc. (CODX)

Stock Price: $18.89 USD -0.57 (-2.93%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 518.66M
Revenue (ttm) 1.76M
Net Income (ttm) -5.89M
Shares Out 27.46M
EPS (ttm) -0.32
PE Ratio n/a
Forward PE 9.74
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $18.89
Previous Close $19.46
Change ($) -0.57
Change (%) -2.93%
Day's Open 19.51
Day's Range 18.75 - 20.56
Day's Volume 2,801,756
52-Week Range 0.80 - 29.72

More Stats

Market Cap 518.66M
Enterprise Value 501.30M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 27.46M
Float 24.28M
EPS (basic) -0.32
EPS (diluted) -0.32
FCF / Share -0.25
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.28M
Short Ratio 0.37
Short % of Float 12.98%
Beta -1.32
PE Ratio n/a
Forward PE 9.74
P/FCF Ratio n/a
PS Ratio 294.68
PB Ratio 26.79
Revenue 1.76M
Operating Income -5.72M
Net Income -5.89M
Free Cash Flow -5.71M
Net Cash 17.37M
Net Cash / Share 0.63
Gross Margin 5.83%
Operating Margin -325.05%
Profit Margin -334.80%
FCF Margin -324.15%
ROA -26.88%
ROE -47.65%
ROIC -469.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(78.24% upside)
Current: 18.89
Target: 33.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth438.63%420.9%---
Gross Profit0.100.030.01-0.01
Operating Income-5.89-6.12-4.56-1.69-1.97
Net Income-6.20-6.27-6.96-1.93-2.04
Shares Outstanding16.7612.4810.969.889.36
Earnings Per Share-0.36-0.50-0.63-0.20-0.22
Operating Cash Flow-5.53-4.08-3.21-1.31-1.53
Capital Expenditures-0.11-0.04-0.13-0.01-0.12
Free Cash Flow-5.64-4.12-3.34-1.32-1.65
Cash & Equivalents0.890.953.531.000.03
Total Debt-1.91-3.391.01
Net Cash / Debt0.89-0.963.53-2.40-0.98
Book Value1.74-1.063.85-2.99-1.15
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Co-Diagnostics, Inc.
Country United States
Employees 29
CEO Dwight Howard Egan

Stock Information

Ticker Symbol CODX
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: CODX
IPO Date July 12, 2017


Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.